Home
Conditions
Recurrent Rectal Cancer

Clinical trial condition

Recurrent Rectal Cancer

Explore clinical trials studying Recurrent Rectal Cancer. Study availability and eligibility vary by location and protocol.

57 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Rectal Cancer trial results

Completed

Supportive Intervention Programs Study

NCT01590147

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +23 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Phase I/II Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Recurrent Rectal Cancer

NCT01528683

Conditions: Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations: University Hospital of Heidelberg, Radiation Oncology Heidelberg, Germany

View Trial Details

Completed

MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

NCT02041481

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +16 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer

NCT01191684

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +28 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer

NCT01821105

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +25 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

Conditions: Adenocarcinoma, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, +135 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

NCT00100841

Conditions: Adenocarcinoma of the Rectum, Colonic Diseases, Colonic Neoplasms, +17 more
Locations: Montefiore Medical Center The Bronx, New York, United States

View Trial Details

Completed

Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer

NCT01294826

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Swedish Medical Center Cancer Institute Seattle, Washington, United States

View Trial Details

Completed

Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT01205022

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +14 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer

NCT00032110

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Colonic Diseases, +16 more
Locations: Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

View Trial Details

Recurrent Rectal Cancer

Recurrent Rectal Cancer trial results

Related conditions